Eli Lilly's Foundayo Pill Approval Sends Stock Soaring
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Eli Lillys new weight-loss pill, Foundayo, gains FDA approval, sending stocks up 4%. Unlike weekly injection Zepbound, Foundayo is a daily oral option, starting shipments on April 6th through LillyDirect. Analysts praise its convenience and effectiveness, expecting strong demand and further stock growth.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/5f3bc9d2d1181df3